Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
OBJECTIVES To describe clinicopathologic features and to identify prognostic factors in a large series of primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL LT), as defined in the… Expand
Prediction of survival for patients with bullous pemphigoid: a prospective study.
OBJECTIVE To identify the prognostic factors of bullous pemphigoid (BP). DESIGN Prospective study of patients with BP included in a randomized, controlled trial. SETTING Twenty dermatology… Expand
Urticarial eruption in COVID‐19 infection
- D. Henry, M. Ackerman, E. Sancelme, A. Finon, É. Estève
- Journal of the European Academy of Dermatology…
- 15 April 2020
Abstract Coronavirus disease (COVID‐19) is spreading quickly across the world, until a pandemic condition was announced by the WHO on March. Many clinical manifestations of this virus are described… Expand
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.
- T. Jouary, C. Leyral, +20 authors J. Grob
- Annals of oncology : official journal of the…
- 1 April 2012
BACKGROUND The treatment of stage I Merkel cell carcinoma (MCC) usually includes wide local excision (WLE) combined with irradiation of the tumor bed (ITB). No randomized study has ever been… Expand
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans
- L. Martin, F. Piette, +15 authors B. Guillot
- The British journal of dermatology
- 1 November 2005
Background Some cases of dermatofibrosarcoma protuberans (DFSP) do not protrude above the skin.
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas.
Bcl-2 protein expression has been associated with poor prognosis in patients with noncutaneous diffuse large B-cell lymphomas. In primary cutaneous large B-cell lymphomas, the location on the leg,… Expand
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
Prognostic studies of primary cutaneous lymphomas (PCL) other than mycosis fungoides (MF) and the Sézary syndrome (SS; non-MF/SS PCL) have been mainly performed on subgroups or on small numbers of… Expand
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France.
IMPORTANCE Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), occurs in elderly patients and has been considered as a lymphoma with a poor prognosis, with estimated 5-year… Expand
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma
Merkel cell polyomavirus (MCPyV) is the main aetiological agent of Merkel cell carcinoma (MCC). Serum antibodies against the major MCPyV capsid protein (VP1) are detected in the general population,… Expand
Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.
BACKGROUND Lymphomatoid papulosis (LyP) is classified as an indolent cutaneous lymphoma, but outcome dramatically worsens if LyP is associated with lymphoma. The frequency of this association remains… Expand